OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations
Charlotte R. Bell, Victoria S. Pelly, Agrin Moeini, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 71
Charlotte R. Bell, Victoria S. Pelly, Agrin Moeini, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer
Nicoletta Caronni, Federica La Terza, Francesco Maria Vittoria, et al.
Nature (2023) Vol. 623, Iss. 7986, pp. 415-422
Closed Access | Times Cited: 137
Nicoletta Caronni, Federica La Terza, Francesco Maria Vittoria, et al.
Nature (2023) Vol. 623, Iss. 7986, pp. 415-422
Closed Access | Times Cited: 137
Platinum Prodrug Nanoparticles with COX‐2 Inhibition Amplify Pyroptosis for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer
Bingzheng Yu, Yushu Wang, Tiejun Bing, et al.
Advanced Materials (2023) Vol. 36, Iss. 11
Closed Access | Times Cited: 56
Bingzheng Yu, Yushu Wang, Tiejun Bing, et al.
Advanced Materials (2023) Vol. 36, Iss. 11
Closed Access | Times Cited: 56
Lipids as mediators of cancer progression and metastasis
Felix C. E. Vogel, Adriano B. Chaves‐Filho, Almut Schulze
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 16-29
Closed Access | Times Cited: 50
Felix C. E. Vogel, Adriano B. Chaves‐Filho, Almut Schulze
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 16-29
Closed Access | Times Cited: 50
Cancer immune evasion, immunoediting and intratumour heterogeneity
Malte Roerden, Stefani Spranger
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 8
Malte Roerden, Stefani Spranger
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 8
Comprehensive characterization of HER2-low breast cancers: implications in prognosis and treatment
Yuyang Li, Julia Y. Tsang, Fiona Tam, et al.
EBioMedicine (2023) Vol. 91, pp. 104571-104571
Open Access | Times Cited: 31
Yuyang Li, Julia Y. Tsang, Fiona Tam, et al.
EBioMedicine (2023) Vol. 91, pp. 104571-104571
Open Access | Times Cited: 31
Apoptosis in mesenchymal stromal cells activates an immunosuppressive secretome predicting clinical response in Crohn’s disease
Tik Shing Cheung, Chiara Giacomini, Matteo Cereda, et al.
Molecular Therapy (2023) Vol. 31, Iss. 12, pp. 3531-3544
Open Access | Times Cited: 23
Tik Shing Cheung, Chiara Giacomini, Matteo Cereda, et al.
Molecular Therapy (2023) Vol. 31, Iss. 12, pp. 3531-3544
Open Access | Times Cited: 23
Tumor Cell–Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer
Samara P. Singh, Austin R. Dosch, Siddharth Mehra, et al.
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1320-1332
Open Access | Times Cited: 15
Samara P. Singh, Austin R. Dosch, Siddharth Mehra, et al.
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1320-1332
Open Access | Times Cited: 15
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 13
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 13
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
Xiao Dong, Xia Shu, Shubo Du, et al.
ACS Central Science (2023) Vol. 9, Iss. 10, pp. 1864-1893
Open Access | Times Cited: 21
Xiao Dong, Xia Shu, Shubo Du, et al.
ACS Central Science (2023) Vol. 9, Iss. 10, pp. 1864-1893
Open Access | Times Cited: 21
Deciphering the roles of aryl hydrocarbon receptor (AHR) in regulating carcinogenesis
Zhi Xiong Chong, Chean Yeah Yong, Han Kiat Ong, et al.
Toxicology (2023) Vol. 495, pp. 153596-153596
Open Access | Times Cited: 18
Zhi Xiong Chong, Chean Yeah Yong, Han Kiat Ong, et al.
Toxicology (2023) Vol. 495, pp. 153596-153596
Open Access | Times Cited: 18
Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette–Guérin Immunotherapy of Bladder Cancer
Omar M. Ibrahim, Paweł Kaliński
Cells (2024) Vol. 13, Iss. 8, pp. 699-699
Open Access | Times Cited: 7
Omar M. Ibrahim, Paweł Kaliński
Cells (2024) Vol. 13, Iss. 8, pp. 699-699
Open Access | Times Cited: 7
Integration of STING activation and COX-2 inhibition via steric-hindrance effect tuned nanoreactors for cancer chemoimmunotherapy
Pengfei Zhang, Di Zhong, Yongbo Yu, et al.
Biomaterials (2024) Vol. 311, pp. 122695-122695
Closed Access | Times Cited: 7
Pengfei Zhang, Di Zhong, Yongbo Yu, et al.
Biomaterials (2024) Vol. 311, pp. 122695-122695
Closed Access | Times Cited: 7
Activated platelets facilitate hematogenous metastasis of breast cancer by modulating the PDGFR-β/COX-2 axis
Yu Tang, Cheng Qian, Yueke Zhou, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107704-107704
Open Access | Times Cited: 15
Yu Tang, Cheng Qian, Yueke Zhou, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107704-107704
Open Access | Times Cited: 15
The antidepressive mechanism of Longya Lilium combined with Fluoxetine in mice with depression-like behaviors
Huina Ma, Hehua Huang, Chenyu Li, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Huina Ma, Hehua Huang, Chenyu Li, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Enhancing therapeutic efficacy in triple‐negative breast cancer and melanoma: synergistic effects of modulated electro‐hyperthermia (mEHT) with NSAIDs especially COX‐2 inhibition in in vivo models
Nino Giunashvili, Mbuotidem Jeremiah Thomas, Csaba András Schvarcz, et al.
Molecular Oncology (2024) Vol. 18, Iss. 4, pp. 1012-1030
Open Access | Times Cited: 5
Nino Giunashvili, Mbuotidem Jeremiah Thomas, Csaba András Schvarcz, et al.
Molecular Oncology (2024) Vol. 18, Iss. 4, pp. 1012-1030
Open Access | Times Cited: 5
Disaggregation‐Activated pan‐COX Imaging Agents for Human Soft tissue Sarcoma
Kyung Tae Hong, Seung Bin Park, Dhiraj P. Murale, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 24
Open Access | Times Cited: 5
Kyung Tae Hong, Seung Bin Park, Dhiraj P. Murale, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 24
Open Access | Times Cited: 5
Liposomal celecoxib combined with dendritic cell therapy enhances antitumor efficacy in melanoma
Vajiheh Jahani, Mona Yazdani, Ali Badiee, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 453-464
Closed Access | Times Cited: 13
Vajiheh Jahani, Mona Yazdani, Ali Badiee, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 453-464
Closed Access | Times Cited: 13
Discovery of 2H-Indazole-3-carboxamide Derivatives as Novel Potent Prostanoid EP4 Receptor Antagonists for Colorectal Cancer Immunotherapy
Zhiyuan Cheng, Yijie Wang, Yao Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6218-6238
Closed Access | Times Cited: 12
Zhiyuan Cheng, Yijie Wang, Yao Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6218-6238
Closed Access | Times Cited: 12
Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors
Brian J. Francica, Anja Holtz, Justine Lopez, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 8, pp. 1486-1500
Open Access | Times Cited: 12
Brian J. Francica, Anja Holtz, Justine Lopez, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 8, pp. 1486-1500
Open Access | Times Cited: 12
Phenylsulfonimide PPARα Antagonists Enhance Nrf2 Activation and Promote Oxidative Stress-Induced Apoptosis/Pyroptosis in MCF7 Breast Cancer Cells
M. Gallorini, Valentina Di Valerio, Isabella Bruno, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1316-1316
Open Access | Times Cited: 11
M. Gallorini, Valentina Di Valerio, Isabella Bruno, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1316-1316
Open Access | Times Cited: 11
Bioengineered NanoAid synergistically targets inflammatory pro-tumor processes to advance glioblastoma chemotherapy
Zhang Gui, Yurui Xu, Anwei Zhou, et al.
Nanoscale (2025)
Closed Access
Zhang Gui, Yurui Xu, Anwei Zhou, et al.
Nanoscale (2025)
Closed Access
Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy
Tao Xu, Kehan Liu, Shu-qi Mi, et al.
Materials Today Bio (2025), pp. 101530-101530
Open Access
Tao Xu, Kehan Liu, Shu-qi Mi, et al.
Materials Today Bio (2025), pp. 101530-101530
Open Access
The Potential Role of PD-1/PD-L1 Small Molecule Inhibitors in Colorectal Cancer with Different Mechanisms of Action
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
A DNA Nanopatch‐Bacteriophage System Targeting Streptococcus Gallolyticus for Inflammatory Bowel Disease Treatment and Colorectal Cancer Prevention
Yadan Zhao, Mengna Zhu, Yufan Ling, et al.
Advanced Materials (2025)
Closed Access
Yadan Zhao, Mengna Zhu, Yufan Ling, et al.
Advanced Materials (2025)
Closed Access
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer
Maria Tredicine, Matteo Mucci, Antonio Recchiuti, et al.
FEBS Letters (2025)
Open Access
Maria Tredicine, Matteo Mucci, Antonio Recchiuti, et al.
FEBS Letters (2025)
Open Access
